Zhi Chen

Artificial intelligence (AI) as a catalyst for mechanistic target discovery: Integrating systems pharmacology and multimodal data.

It is demonstrated that this AI-driven paradigm is essential for advancing precision medicine, as it systematically translates vast and heterogeneous datasets into testable mechanistic hypotheses, and accelerates the development of safer, more effective and patient-specific therapies.